Q32 Bio (QTTB) Short term Debt (2023 - 2026)

Q32 Bio (QTTB) recorded quarterly Short term Debt of $6.2 million in Q1 2026, little changed quarter-over-quarter from $6.2 million in Q4 2025, and up 33.83% on a YoY basis from $4.7 million in Q1 2025.

Q32 Bio (QTTB) Short term Debt (2023 - 2026) Analysis & Trends

Q32 Bio's Short term Debt history runs 4 years deep, the most recent figure standing at $6.2 million for Q1 2026.

  • In Q1 2026, Short term Debt rose 33.83% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $6.2 million (up 33.83% YoY), while the FY2025 annual figure was $6.2 million, up 101.32% from the prior year.
  • Short term Debt was $6.2 million for Q1 2026 at Q32 Bio, roughly flat from $6.2 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $6.2 million in Q1 2026 to a low of $878000.0 in Q4 2023.
  • Historically, Short term Debt has averaged $4.2 million across 4 years, with a median of $4.7 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: Short term Debt surged 306.52% in 2025, then surged 33.83% in 2026.
  • A 4-year view of Short term Debt shows it stood at $878000.0 in 2023, then jumped by 252.73% to $3.1 million in 2024, then jumped by 101.32% to $6.2 million in 2025, then advanced by 0.06% to $6.2 million in 2026.
  • The last three Short term Debt figures came in at $6.2 million (Q1 2026), $6.2 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Q32 Bio 167.59 Mn 116.84 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 6.24 Mn
Dec 31, 2025 6.24 Mn
Sep 30, 2025 6.23 Mn
Jun 30, 2025 6.23 Mn
Mar 31, 2025 4.66 Mn
Dec 31, 2024 3.10 Mn
Sep 30, 2024 1.53 Mn
Mar 31, 2024 3.09 Mn
Dec 31, 2023 878,000.00